**Core Concept**
Intranasal calcitonin is a form of calcitonin, a hormone that plays a crucial role in regulating calcium and phosphorus metabolism. Calcitonin is secreted by the thyroid gland and helps to decrease blood calcium levels by inhibiting osteoclast activity and promoting calcium deposition in bones.

**Why the Correct Answer is Right**
Intranasal calcitonin is used to treat osteoporosis, particularly in postmenopausal women. It works by mimicking the natural effects of calcitonin, thereby reducing bone resorption and increasing bone density. The intranasal route of administration allows for direct absorption into the bloodstream, thereby bypassing first-pass metabolism and ensuring efficacy.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect as intranasal calcitonin is not primarily used for the treatment of hypercalcemia. While it may have some effect on reducing blood calcium levels, its primary indication is for the prevention and treatment of osteoporosis.
* **Option B:** This option is incorrect as intranasal calcitonin is not a form of hormone replacement therapy. While it may have some effects on bone density, its primary mechanism of action is through the inhibition of osteoclast activity, rather than through the replacement of estrogen.
* **Option C:** This option is incorrect as intranasal calcitonin is not primarily used for the treatment of Paget's disease. While it may have some effect on reducing bone turnover, its primary indication is for the prevention and treatment of osteoporosis.

**Clinical Pearl / High-Yield Fact**
Intranasal calcitonin is a useful adjunctive therapy in the management of osteoporosis, particularly in patients who are unable to tolerate oral bisphosphonates or have a high risk of osteoporotic fractures.

**Correct Answer: C. Treatment of osteoporosis**